stockchase picture

Compiling comments that experts make about stocks while on public TV.

Expert Index

List by First Name

List by Last Name

Stan Wong , Director of Wealth Management & Portfolio Manager

Private Wealth Management, ScotiaMcleod

Address
675 Cochrane Drive
Suite 115
Markham, ON
L3R 0B8

Contact Info
Telephone: 905-752-1996
Toll Free: 1-855-752-1996
Fax: 905-752-1995
Email:
Website: http://www.stanwong.com

Bio:

Stan Wong is one of Canada’s leading investment professionals. With over 17 years of experience, he provides industry leading wealth management and investment counsel to affluent families, small business owners and institutional clients in Canada. 
As a qualified and registered Portfolio Manager, Stan retains one of the highest levels of registration in the investment services industry. The Portfolio Manager title is a designation that requires a high level of academic achievement and success in the investment industry.
Stan recently joined ScotiaMcLeod as Director of Wealth Management & Portfolio Manager in January 2014. Prior to joining ScotiaMcLeod, Stan held senior positions at Macquarie Private Wealth and its predecessor firm. Stan has also worked at CIBC Wood Gundy and Merrill Lynch. Stan earned his Honours Bachelor of Arts degree in Economics from the University of Toronto in 1996. 
Today, Stan is also a frequent guest commentator on Business News Network (BNN) television, The Globe & Mail, Reuters and the Wall Street Journal.


Date Signal Chart Symbol Company Opinion Price
2015-06-25 N/A Must be logged in to use chart A Commentary A Comment -- General Comments From an Expert

Markets. For the last several months North American equity markets have been trading in a very narrow trading range. There is anxiety among investors regarding equity valuations. The S&P is trading at around 17-18 times PE earnings and the same with the TSX. There are geopolitical pressures that stem from Greece which is at the forefront right now. US$ headwinds are talked about all the time. There is an eventual pending liftoff of US interest rates, and investors are worried about the trajectory of interest rates. Expect this sideways pattern will continue, especially given the fact that we will traditionally have some seasonal summer weakness in the months ahead. We need to see the earnings backdrop improve before we see a more meaningful advance for the markets. Expects some market swings that will be driven once again by global central bank inactions. Volatility is the key. We’ll probably see plenty of market movement, but probably not a lot of direction or conviction. Equities still look better than bonds, certainly with interest rates moving up, and they still look better than cash.


Price:
$0.020
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
_N/A
2015-06-25 TOP PICK Must be logged in to use chart AAPL-Q Apple

The valuation on this is still very, very solid. Trading on a 13 X forward PE multiple with a 15% long-term growth rate. That puts it at a PEG ratio of 1.0%. Balance sheet is unbeatable with $94 billion in cash. That allowed them to do a $140 billion share buyback. Yield of 1.63%.


Price:
$127.500
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
Yes
2015-06-25 BUY Must be logged in to use chart BAC-N Bank of America

He likes the US financials, especially when compared to the Canadian ones. This is trading at a 0.8 price to BV and 13X forward earnings. Has a 9% growth rate.


Price:
$17.370
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
No
2015-06-25 COMMENT Must be logged in to use chart COST-Q Costco Wholesale

The share price has been suffering. However, long term he expects they will continue to capture market share, especially with the economy improving. The issue is that the stock is trading at 26X forward PE, with an expected 10% long-term growth rate. This puts it at 2.6X Peg Ratio, which is rather high. There are some foreign exchange headwinds, as 30% of its revenues come from international markets. He would prefer the dollar stores at this time.


Price:
$137.450
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
No
2015-06-25 COMMENT Must be logged in to use chart CSH.UN-T Chartwell Seniors Housing

Has been moved out of the REIT Index, which is part of the reason for its drop. Dividend of about 4.8%, which should grow about 5.4%. The demographics certainly make sense. He is relatively neutral on REITs, given that rising interest rates are not great for real estate trusts.


Price:
$11.480
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
No
2015-06-25 TOP PICK Must be logged in to use chart CVS-N CVS Health Corp

The price has done very well, but the valuations are still very reasonable for a name like this. The Affordable Care Act is something that will benefit companies like this for a very, very long time. You can expect to see an increase in generic drug sales and specialty drugs as well. The recent acquisition of Omnicare (OCR-N) is very solid. They bought Target’s (TGT-N) 1,600 pharmacies, which will give them more exposure and scale with the ability of more purchasing power. 20X forward PE with a 14% long-term growth and 1.4 PEG ratio. Dividend yield of 1.33%.


Price:
$105.010
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
Yes
2015-06-25 TOP PICK Must be logged in to use chart DIS-N Walt Disney

The most dominant media entertainment name out there with its multiplatform of theme parks, consumer products, films and television. Have done brilliant acquisitions, which are going to spell benefits for a very, very long time to come. Just announced they are going to pay a dividend twice a year instead of just once. Dividend yield of 1.15%.


Price:
$114.450
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
Yes
2015-06-25 PAST TOP PICK Must be logged in to use chart EFA-N iShares MSCI EAFE E.T.F.

(A Top Pick June 24/14. Down 1.05%.) The actual investment itself was up 14.5%, but because of the rising US$, it has taken away from the returns, so he moved into Wisdomtree International Hedged Equity Fund (HEDJ-N) giving exposure to Europe.


Price:
$65.770
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
No
2015-06-25 COMMENT Must be logged in to use chart GE-N General Electric

Nice dividend at 3.4%, which should grow by about 4%-5% on a yearly basis. Trading at about 19X forward earnings, with a decent growth rate in the high single digit/low double-digit. Valuations are getting a bit stretched, but technically it is breaking out a little bit and is above the 50 day moving average.


Price:
$27.040
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
Yes
2015-06-25 PAST TOP PICK Must be logged in to use chart GOOGL-Q Google

(A Top Pick June 24/14. Down 2.55%.) This seems to be a tech name that has taken the year off. He still likes it. Trading at 19X Forward Price Earnings with a 17% expected long-term growth. PEG ratio is just over 1 which offers pretty good value. They are putting a lot of money into R&D. A lot of things are happening. They are monetizing YouTube, getting into glasses, etc., etc.


Price:
$557.950
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
Yes
2015-06-25 COMMENT Must be logged in to use chart HDV-N iShares High Dividend Equity

Pretty well diversified amongst different sectors. The idea is to get a very high dividend for shareholders. He would be cautious about being too overweight in dividend paying names, because as interest rates start to move up, these would be proxy for bonds and could have a sideways movement.


Price:
$74.720
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
No
2015-06-25 PARTIAL BUY Must be logged in to use chart IBB-Q iShares Nasdaq BioTech ETF

Within the healthcare space, biotech is one of the better valued areas. When you look at some of the names, they offer very good value as well as very good growth. This one has done well, so layer into it at this time.


Price:
$375.840
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
Unknown
2015-06-25 COMMENT Must be logged in to use chart IHF-N iShares US Healthcare Providers

In the healthcare sector, this is one that he has been looking at. This will have the hospital names, some of the pharmacy benefit managers, etc. Has taken a bit of a run and is kind of scary to be buying it, but healthcare in this particular space, are the ones that are going to benefit the most.


Price:
$145.570
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
No
2015-06-25 COMMENT Must be logged in to use chart JNJ-N Johnson & Johnson

This is above 45% in the pharmaceutical space, and the rest is in devices, etc. Not necessarily his favourite when looking at pharmaceuticals. Trading at about 16X forward earnings with a 7% long-term growth and a 2.3 PEG ratio. When you get north of 2 it is a bit expensive.


Price:
$99.120
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
Unknown
2015-06-25 DON'T BUY Must be logged in to use chart LVS-N Las Vegas Sands Corp.

Technicals show that this is starting to form a bit of a base, but it is falling. Both the 200 and 60 day moving averages are falling. The stock price is below both of those numbers. He would stay away for the time being.


Price:
$51.580
Subject:
NORTH AMERICAN - LARGE & ETFs
Bias:
CAUTIOUS
Owned:
No
Showing 1 to 15 of 1,109 entries
First Previous 1 2 3 4 5 Next Last

No Comments.


You must be logged in to comment.